EP1051215A1 - Dispositif permettant d'injecter un fluide dans la paroi d'un vaisseau sanguin - Google Patents

Dispositif permettant d'injecter un fluide dans la paroi d'un vaisseau sanguin

Info

Publication number
EP1051215A1
EP1051215A1 EP98903898A EP98903898A EP1051215A1 EP 1051215 A1 EP1051215 A1 EP 1051215A1 EP 98903898 A EP98903898 A EP 98903898A EP 98903898 A EP98903898 A EP 98903898A EP 1051215 A1 EP1051215 A1 EP 1051215A1
Authority
EP
European Patent Office
Prior art keywords
fluid
balloon
treatment area
expander
releasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98903898A
Other languages
German (de)
English (en)
Other versions
EP1051215A4 (fr
Inventor
Dennis M. Vigil
Robert E. Reiss
Peter Barath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
InterVentional Technologies Inc
Original Assignee
InterVentional Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by InterVentional Technologies Inc filed Critical InterVentional Technologies Inc
Priority claimed from PCT/US1998/001984 external-priority patent/WO1999038559A1/fr
Publication of EP1051215A1 publication Critical patent/EP1051215A1/fr
Publication of EP1051215A4 publication Critical patent/EP1051215A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M29/00—Dilators with or without means for introducing media, e.g. remedies

Definitions

  • the present invention pertains generally to medical devices useful for injecting fluid into a patient. More specifically, the present invention pertains to medical devices inserted into a vessel of a patient's cardiovascular system which are useful for injecting fluid directly into a vessel wall.
  • fluid can be infused directly into wall of a blood vessel to treat some ailments.
  • medicaments can be administered into an arterial wall to inhibit or prevent the restenosis of plaque in the artery.
  • the procedure must insure that only minimal amounts of medication are washed away into the blood stream and not actually infused into the vessel wall.
  • the device for administering the fluid into the arterial wall must be easy to use, accurate and reliable.
  • a device for medicating a vessel wall is disclosed in U.S. Patent Nos. 5,112,305 and 5,242,397 which issued to Barath et al.
  • the device disclosed in the Barath et al. patents employs a balloon which initial is slowly filled with a medicament to expand the balloon and position the balloon's surface against the vessel wall. Subsequently, the balloon is rapidly filled. The rapid filling of the balloon reconfigures tubular extensions on the surface of the balloon for insertion into the vessel wall and infusion of medicaments through the tubular extensions.
  • this device has proved not to be entirely satisfactory. Specifically, with this device, the mechanism for infusing a fluid into a vessel wall is not independent and separately operable from the mechanisms which position the device in the artery and which cause penetration into the vessel wall. Further, this device does have the capability of selectively applying a variable force to the fluid injectors of the device as they penetrate into the vessel wall.
  • an object of the present invention to provide a device for injecting fluid into a wall of a vessel having a mechanism for penetrating the vessel wall that is separate from the mechanism which injects the fluid into the vessel wall. It is another object of the present invention to provide a device for injecting fluid into the wall of a vessel which can selectively vary the force that is used to penetrate the vessel wall. Still another object of the present invention is to provide a device for injecting fluid into the wall of a vessel which is easy to use, and relatively simple and inexpensive to manufacture. Yet another object of the present invention is to provide a device for injecting radioactive isotopes into a wall of a vessel.
  • a device for injecting a fluid from a fluid source into a treatment area of a wall of a vessel includes an expander and one or more injectors.
  • the device includes a plurality of injectors for distributing the fluid into a larger treatment area.
  • the expander includes a balloon which is expandable from a contracted, first configuration to an expanded second configuration.
  • the injectors extend radially from the balloon and move radially with the balloon between the first configuration and the second configuration.
  • the injectors penetrate the treatment area and selectively release the fluid when the balloon is at the second configuration.
  • the balloon can simultaneously dilate the vessel when the balloon is in its second configuration.
  • an inflator selectively controls the expansion of the balloon and the fluid source selectively provides a pressurized supply of fluid to the injectors.
  • the mechanism which causes the injectors to penetrate the vessel wall is separate from the mechanism which releases the fluid into the vessel wall.
  • At least one fluid passageway connects the fluid source in fluid communication with the injectors.
  • the fluid passageway can include a flexible tubular sleeve which substantially encompasses and encloses at least a portion of an outer surface of the balloon.
  • the tubular sleeve cooperates with the outer surface of the balloon to form a portion of the fluid passageway.
  • a distal end of the tubular sleeve attaches directly to the outer surface of the balloon and an open proximal end of the sleeve extends proximally from the balloon for connection with the fluid source.
  • Each injector can be a substantially tubular protrusion having an attachment end and an open cutting edge.
  • the attachment end includes a base plate which mounts directly onto the tubular sleeve.
  • a plurality of tubular protrusions can be mounted onto the same base plate.
  • Each tubular protrusion includes a fluid channel through the injector which is placed in fluid communication with the fluid passageway.
  • the base plate of the injector can be mounted onto the tubular sleeve over holes that may either be preformed into the tubular sleeve or formed into the tubular sleeve after the injectors have been attached to the tubular sleeve.
  • the inflator can be directly connected to a lumen of a catheter.
  • the catheter lumen is in fluid communication with an interior of the balloon to inflate and deflate the balloon between the first and second configurations.
  • the fluid source includes a fluid pump which is in fluid communication with the fluid passageway for selectively providing a pressurized supply of fluid from the fluid source to the injectors.
  • the invention is also a method for expanding the treatment area and delivering fluid from the fluid source to the treatment area.
  • the method includes advancing the balloon in the vessel while the balloon at its first configuration, expanding the balloon to its second configuration and selectively releasing the fluid from the injector into the treatment area.
  • the balloon is advanced in the vessel until the balloon is positioned substantially adjacent the treatment area.
  • the balloon is expanded to its second configuration.
  • the expansion of the balloon causes the cutting edge of at least one injector which moves with the balloon to penetrate the treatment area.
  • the expansion of the balloon can also cause simultaneous dilation of the vessel.
  • the fluid can be released substantially simultaneously with the cutting edge penetrating the treatment area or there can be a time delay between the cutting edge penetrating the treatment area and the release of the fluid from the injectors.
  • the expander in a second version of the present invention, includes a multi-lumen catheter and a grommet.
  • the catheter and the grommet are both disposed about the same longitudinal axis with the grommet separated distally from the distal end of the multi-lumen catheter.
  • the grommet is movable in translation along the longitudinal axis to allow separation between the grommet and the multi-lumen catheter to either increase or decrease.
  • the second version includes a plurality of hollow, flexible, tubes which are each formed with a lumen and which each have a distal end, a central region, and a proximal end.
  • the distal end of each of the tubes is attached to the grommet.
  • the proximal end of each of the tubes is attached to the catheter.
  • the attachment between the tubes and the catheter, as well as the attachment between the tubes and the grommet arranges the plurality of tubes radially around the catheter. In this arrangement, the attachment between the multi- lumen catheter and the plurality of tubes is such that the lumen of each tube is connected in fluid communication with a respective lumen of the multi-lumen catheter.
  • fluid may be supplied under pressure to pass through the multi-lumen catheter and into the plurality of tubes.
  • each tube is connected to an individual lumen within the catheter.
  • the plurality of tubes may be connected singly, or in combination, to one or more common lumens within the multi-lumen catheter.
  • the plurality of injectors are attached to the central region of each flexible tube and project radially outward from the longitudinal axis.
  • the fluid is passed through the multi-lumen catheter, the lumens of the flexible tubes and out of the injectors.
  • a push-pull wire is connected to the grommet and passed through one of the lumens of the multi-lumen catheter.
  • the insertion of the push-pull wire through the multi-lumen catheter allows the push-pull wire to be moved translationally along the longitudinal axis of the present invention.
  • the translational movement of the push-pull wire causes the grommet to move translationally with respect to the multi-lumen catheter.
  • the push-pull wire may be used to increase, or decrease, the separation between the grommet and the multi-lumen catheter.
  • each of the flexible tubes arches, or bows, outwardly, from the longitudinal axis, giving the device an expanded configuration.
  • each of the flexible tubes straightens, or flattens, giving the device a contracted configuration.
  • a device in accordance with the present invention utilizes a mechanism which causes the injectors to penetrate the vessel wall that is separate from the mechanism which releases the fluid into the vessel wall. Further, the device can vary the force that is used to penetrate the vessel wall and can simultaneously dilate the vessel wall. Additionally, the present invention is particularly useful for injecting radioactive isotopes directly into the vessel wall.
  • Figure 1 is a perspective view of a patient with a device having features of the present invention positioned in an artery of the patient;
  • Figure 2 is a perspective view of a device having features of the present invention
  • Figure 3 is a cross-sectional view of the device of Figure 2 taken on line 3-3 in Figure 2 positioned in an artery of a patient;
  • Figure 4A is a perspective view of an embodiment for an injector having features of the present invention
  • Figure 4B is a perspective view of another embodiment for an injector having features of the present invention
  • Figure 5A is a perspective view of an embodiment of a plurality of injectors having features of the present invention.
  • Figure 5B is a perspective view of another embodiment of a plurality injector of the present invention.
  • Figure 6 is a perspective view of another embodiment of a device having features of the present invention.
  • Figure 7 is a cross-sectional view taken on line 7-7 of Figure 6.
  • Figure 8 is a perspective view of yet another embodiment of a device having features of the present invention.
  • Figure 9 is a cross-sectional view of the device of Figure 8 shown in a retracted configuration, as seen along line 9-9 in Figure 8;
  • Figure 10 is a cross-sectional view of the device of Figure 8 shown in an expanded configuration, as seen along the line 9-9 in Figure 8; and Figure 11 is a cross-sectional view of the device of Figure 8 positioned in a blood vessel of the patient.
  • a device 10 for injecting a fluid 13 into a wall of a blood vessel 1 1 in accordance with the present invention is shown positioned in an upper body, blood vessel 1 1 of a patient 12.
  • the use of the device 10 is not confined to only upper body blood vessels 1 1 but, instead, can be used in arteries and vessels throughout the patient 12.
  • the device 10 provided herein allows for symmetric injection of the fluid 13 directly in the vessel 1 1 around the circumference of the vessel 11.
  • a first version of a device 10 having features of the present invention includes a multi-lumen catheter 14, an expander mounted thereon, a tubular sleeve 18 and a plurality injectors 20.
  • the expander can be an inflatable balloon 16.
  • the balloon 16 is at least inflated and deflated between a first, substantially retracted configuration and a second, substantially expanded configuration.
  • the balloon 16 when at the first configuration is substantially deflated.
  • the balloon 16 when at the second configuration can be anywhere from the partially inflated to fully inflated depending upon the size of the vessel 11.
  • the balloon 16 and tubular sleeve 18 are preferably made of polyethylene terephthalate (PET).
  • Figure 2 indicates that the tubular sleeve 18 surrounds a substantial portion of the balloon 16, and that a plurality of injectors 20 are mounted onto the tubular sleeve 18.
  • the injectors 20 shown are only exemplary.
  • FIG. 3 A more complete appreciation of the structural cooperation between balloon 16, tubular sleeve 18 and the injectors 20 is provided by Figure 3 wherein, it will be seen that a distal end 22 of tubular sleeve 18 is attached directly to an outer surface 25 of balloon 16.
  • Figure 3 also shows that the tubular sleeve 18 substantially surrounds and encloses the balloon 16 and that a proximal end 24 of tubular sleeve 18 extends proximally from and beyond the balloon 16 over catheter 14.
  • the tubular sleeve 18 cooperates with the outer surface 25 of the balloon 16 to define a portion of a fluid passageway 26.
  • the proximal end 24 can be connected to an outer lumen 27 (not shown in Figure 3) of the catheter 14 to complete the fluid passageway 26.
  • Figure 3 further shows that the distal end 28 of balloon 16 is affixed to the catheter 14, and that the proximal end of the balloon 16 closes onto the catheter 14 to create an inflation chamber 32 in the interior of the balloon 16
  • a balloon port 34 provides fluid access into the inflation chamber 32
  • the balloon port 34 can be connected in fluid communication with a balloon lumen (not shown) of the catheter 14
  • Figure 3 also shows that catheter 14 is formed with an inner lumen 36 which is dimensioned to receive a guidewire 38 therethrough.
  • each injector 20 includes a base plate 40 and a tubular protrusion 42 having an attachment end 44 and a cutting edge 46. Further, it is seen that the attachment end 44 of the tubular protrusion 42 affixes to and is an integral part of the base plate 40.
  • the injector 20 is made of nickel and the tubular protrusion 42 is formed by punching out the base plate 40 The cutting edge 46 is opposite the base plate 40
  • the tubular protrusion 42 defines a fluid channel 48 which extends through the injector 20
  • Each injector 20 shown in Figure 4A is substantially annular shaped
  • FIG 4B shows another embodiment of the injector 20.
  • Each tubular protrusion 42 shown in Figure 4B is substantially conical shaped
  • the injector 20 in Figure 4B is preferably made of nickel and is formed to have a fluid channel 48 which extends through the injector 20
  • Figure 5A shows a plurality of injectors 20 formed upon the same base plate 50
  • Figure 5A shows an elongated base plate 50 from which the tubular protrusions 42 have been formed.
  • the protrusions 42 shown in Figure 5A are structurally the same as the tubular protrusion 42 discussed above with reference to Figure 4A The only difference being that they are collectively mounted on the same base plate 50
  • Figure 5B shows a plurality injectors 20 formed upon the same base plate 50
  • the protrusions 42 shown in Figure 5B are structurally the same as the tubular protrusion 42 discussed above with reference to Figure 4B. Again, the only difference being that they are collectively mounted on the same base plate 50.
  • the injectors 20 are mounted onto the tubular sleeve 18 so that the fluid channel 48 of each respective injector 20 is aligned with a hole 52 in the tubular sleeve 18. This is done to establish fluid communication between the particular injector 20 and the infusion chamber 26.
  • the injectors 20 of the present invention extend between about 0.005 inches and about 0.02 inches away from the tubular sleeve 18 when the balloon 16 is inflated.
  • the basic components of the device 10 include the multi-lumen catheter 14 formed to accommodate the guide wire 38, the balloon 16, the plurality of injectors 20 and a plurality of tubular channels 64 mounted on the outer surface 25 of balloon 16.
  • Each tubular channel 64 has a smaller diameter than the balloon 16 and is positioned to be substantially parallel with a longitudinal axis 65 of the balloon 16.
  • FIG. 6 further shows that mounted on the surface of each tubular channel 64 is the injectors 20.
  • the injectors 20 are positioned on the surface of tubular channel 64 so that when balloon 16 is inflated, the injectors 20 move outwardly in a radial direction. Note, however, the showing of injectors 20 is for illustration purposes only and it should be appreciated that any injector 20 or combination of injectors 20 discussed in association with the previous embodiments may be used.
  • FIG. 7 the cross-sectional view of device 10 shows the tubular channel 64 in more detail. More specifically, a distal end 66 of tubular
  • 10 channel 64 is sealed to create a portion of the fluid passageway 26 which connects the injectors 20 to the fluid source 60.
  • the proximal (extracorporeal) end 68 of the tubular channel 64 is in fluid communication with the outer lumen 27 of the catheter, which is connected in fluid communication with the fluid pump 58 and the fluid source 60.
  • the injectors 20 are shown mounted on the surface of tubular channel 64.
  • base 40 of each injector 20 is mounted on the tubular channel 64 over a corresponding hole 70. From this view, it can be appreciated that any number of tubular channels 64 could be mounted on the external surface of balloon 16. It is further appreciated that any number of injectors 20 could be mounted on a single tubular channel 64.
  • the composition of the fluid 13 to be injected into the vessel 11 depends upon the treatment being performed and the physical characteristics of the patient 12.
  • the fluid 13 can be antibodies such as receptor site monoclonal antibodies, a toxic agent such as saponin, a genetic material such as DNA, a cellular material such as endothelial cells and/or medicaments such as heparin.
  • the fluid 13 could be a radioactive isotope. It is believed that radioactive isotopes injected into the vessel 11 reduce and inhibit tissue and/or cell growth of the vessel wall.
  • radioactive isotopes are injected directly in the vessel 1 1 and are symmetrically injected around the circumference of the vessel 11 .
  • relatively low energy radioactive isotopes can be utilized.
  • a radioisotope such as technetium 99 or thallium 205, which have a relatively short half life can be utilized with the present invention. These relatively low energy radioactive isotopes should cause less trauma to the patient 12.
  • the radioisotope can be encapsulated within a suitable carrier such as amino-mannose modified liposome, which is rapidly absorbed into smooth muscle cells.
  • FIG. 8 shows a second version of the expander which includes a multi- lumen catheter 80 and a grommet 82. Both the multi-lumen catheter 80 and the grommet 82 are disposed about the same longitudinal axis with the grommet 82 positioned distally, and separated from, the distal end of the multi-lumen catheter 80.
  • a push-pull wire 84 is shown connected to the grommet 82.
  • the push-pull wire 84 extends through one of the lumens of the multi-lumen catheter 80 allowing the push-pull wire 84 to move translationally in line with the longitudinal axis.
  • the translational movement of the push-pull wire 84 causes the grommet 82 to undergo a similar translational displacement.
  • the push-pull wire 84 may be formed with an internal lumen through which the guidewire 38 may be passed.
  • a plurality of hollow, flexible tubes 86 are attached between the grommet 82 and the multi-lumen catheter 80.
  • Each of the flexible tubes 86 includes a distal end 88, a proximal end 90 and a central region 92.
  • the proximal end 90 of each tube 86 is joined to the multi-lumen catheter 80.
  • the distal end 88 of each tube 86 is joined to the grommet 82.
  • the tubes 86 are distributed radially around the multi-lumen catheter 80 and grommet 82 in a manner substantially as shown in Figure 8.
  • each flexible tube 86 is formed with a lumen 94.
  • the lumen 94 of flexible tubes 86 passes through flexible catheter 80 allowing fluid 13 to be passed through multi-lumen catheter 80 and into flexible tubes 86.
  • the lumen 94 of each flexible tube 86 passes separately through multi-lumen catheter 80 allowing a different fluid 13 to be passed into each flexible tube 86.
  • the lumen 94 of each flexible tube 86 may be attached to one or more common lumens within multi-lumen catheter 80.
  • FIGS. 9 and 10 also show that the plurality of injectors 20 are attached to the central region 90 of each tube 86.
  • Each flexible tube 86 is formed with a plurality of holes 96 which correspond to a respective injector 20. Functionally, each hole 96 connects the channel of a respective injector 20 to lumen 94 allowing the fluid pump 58 to pump fluid 13 from the fluid source 60 into lumen 94 to be expelled through the injectors 20.
  • Figures 9, and 10 also show that the present invention is movable between the first, contracted configuration (shown in Figure 9) and the second, expanded configuration (shown in Figure 10).
  • the grommet 82 and the multi-lumen catheter 80 are distanced by a first separation 98.
  • the device 10 shown in Figure 9 also has a first overall width designated 100.
  • the grommet 82 and the multi-lumen catheter 80, shown in Figure 10 is distanced by a second separation 102 which is smaller than the first separation 98 of Figure 9.
  • the device 10, shown in Figure 10 also has a second overall width 104 which is greater than the first overall width 100 shown in Figure 9.
  • the difference between the first, contracted configuration shown in Figure 9 and the second, expanded configuration shown in Figure 10 is accomplished, by translational movement of the grommet 82 along the longitudinal axis.
  • the push-pull wire 84 causes the grommet 82 to move towards the multi-lumen catheter 80, each of the flexible tubes 86 bows outwardly away from the longitudinal axis.
  • the push-pull wire 84 may be used to move the grommet 82 translationally to cause the flexible tubes 86 to alternately bow, as seen in Figure 10, and straighten, as seen in Figure 9.
  • the guidewire 38 is positioned into the vessel 11 of the patient 12. This is done to establish a mechanical pathway through the vessel 11 to the treatment area 54 where the fluid 13 is to be released. The extracorporeal end of the guidewire 38 is then inserted into the catheter 14 lumen.
  • the balloon 16 which is attached to the catheter 14, is moved over the guidewire 38 to the treatment area 54.
  • the balloon 16 is at its first configuration during movement in the vessel 11.
  • an inflator 56 is activated to inflate the balloon 16 to its second configuration.
  • the inflator 56 is connected to the proximal (extracorporeal) end of the device 10.
  • the expanding balloon 16 urges against the tubular sleeve 18 and causes the tubular sleeve 18 to likewise expand. Consequently, the injectors 20 mounted on the tubular sleeve 18 move radially from the catheter 14 and embed into the treatment area 54. Further, the balloon 16 can be used to simultaneously dilate the balloon.
  • the fluid pump 58 shown in Figure 2 is activated to pump fluid 13 from the fluid source 60 into the fluid passageway 26 Importantly, this pumping action also causes any fluid 13 which has already been pumped into the fluid passageway 26 to be expelled through the fluid channels 48 of injectors 20 and into the tissue of treatment area 54
  • the fluid pump 58 could be activated prior to embedding the injectors 20 into the vessel wall 11 and a valve 62 could be used to
  • valve 14 prevent the flow of fluid 13 until the injectors 20 are embedded in the treatment area 54.
  • the valve 62 can then be opened when the injectors 20 penetrate into the treatment area 54 so that injection occurs substantially simultaneously with the embedding of the injectors 20 in the treatment area 54.
  • the injection of the fluid 13 could happen after a time delay by waiting to open the valve 62 for at least about one second to about twenty seconds.
  • the balloon 16 can be deflated to the first configuration by reversing the inflator 56. This action will cause the balloon 16 to collapse and withdraw the injectors 20 from the treatment area 54.
  • the embodiment shown in Figures 6 and 7 utilizes a plurality of individual, tubular channels 64.
  • fluid communication between each tubular channel 64 can be established by fluidly connecting each tubular channel 64 together within one outer lumen 27 of the catheter 14 so that each tubular channel 64 is supplied fluid 13 from the same fluid pump 58.
  • fluid isolation may be maintained between each tubular channel 64 by providing each tubular channel 64 with a corresponding and independent outer lumen 27 and establishing its own fluid connection to a corresponding and independent fluid pump 58. Consequently, it is possible to inject a variety of alternate fluids 13 simultaneously by using a plurality of tubular channels 64 which are each connected to a separate fluid pump 58.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

L'invention concerne un dispositif (10) et un procédé qui permettent d'injecter un fluide dans une zone de traitement. Dans l'un des modes de réalisation, le dispositif comprend un cathéter (14) à ballonnet (6), dont le ballonnet présente une pluralité d'injecteurs (20) dirigés vers l'extérieur. Des conduits fluidiques (26) relient chaque injecteur à une source (60) de fluide. En utilisation, on positionne le ballonnet dans un vaisseau à proximité de la zone de traitement (54) et on le gonfle de façon à faire pénétrer les injecteurs dans la paroi vasculaire. Le fluide passe dans le conduit fluidique (26), traverse les injecteurs (20) et entre dans la zone de traitement (54). Dans le second mode de réalisation, le dispositif comprend des tubes flexibles (64), pourvus desdits injecteurs (20) et montés entre un cathéter (14) à plusieurs lumières et un passe-câble. On fait passer un câble (38) relié au passe-câble dans une lumière (27) du cathéter (14). Une fois le dispositif positionné dans un vaisseau, on retire partiellement le câble, ce qui oblige le passe-câble à avancer vers le cathéter (14) et les tubes flexibles (64) à se déplacer vers l'extérieur, de façon à faire pénétrer les injecteurs (10) dans la paroi vasculaire.
EP98903898A 1998-01-30 1998-01-30 Dispositif permettant d'injecter un fluide dans la paroi d'un vaisseau sanguin Withdrawn EP1051215A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/001984 WO1999038559A1 (fr) 1997-01-10 1998-01-30 Dispositif permettant d'injecter un fluide dans la paroi d'un vaisseau sanguin

Publications (2)

Publication Number Publication Date
EP1051215A1 true EP1051215A1 (fr) 2000-11-15
EP1051215A4 EP1051215A4 (fr) 2001-04-04

Family

ID=22266315

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98903898A Withdrawn EP1051215A4 (fr) 1998-01-30 1998-01-30 Dispositif permettant d'injecter un fluide dans la paroi d'un vaisseau sanguin

Country Status (4)

Country Link
EP (1) EP1051215A4 (fr)
KR (1) KR20010040455A (fr)
CA (1) CA2318132A1 (fr)
IL (1) IL137356A0 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039955A1 (fr) * 1995-06-07 1996-12-19 Dubrul Will R Catheter vibrant
EP0753322A2 (fr) * 1995-07-10 1997-01-15 Interventional Technologies Inc Cathéter pour injecter un médicament liquide dans la parois d'une artérie
EP0783898A1 (fr) * 1996-01-11 1997-07-16 Interventional Technologies Inc Cathéter avec injecteur de médicament liquide
US5676978A (en) * 1989-02-14 1997-10-14 Amira, Inc. Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5676978A (en) * 1989-02-14 1997-10-14 Amira, Inc. Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
WO1996039955A1 (fr) * 1995-06-07 1996-12-19 Dubrul Will R Catheter vibrant
EP0753322A2 (fr) * 1995-07-10 1997-01-15 Interventional Technologies Inc Cathéter pour injecter un médicament liquide dans la parois d'une artérie
EP0783898A1 (fr) * 1996-01-11 1997-07-16 Interventional Technologies Inc Cathéter avec injecteur de médicament liquide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9938559A1 *

Also Published As

Publication number Publication date
EP1051215A4 (fr) 2001-04-04
KR20010040455A (ko) 2001-05-15
CA2318132A1 (fr) 1999-08-05
IL137356A0 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
US5873852A (en) Device for injecting fluid into a wall of a blood vessel
US5746716A (en) Catheter for injecting fluid medication into an arterial wall
US6102904A (en) Device for injecting fluid into a wall of a blood vessel
AU709465B2 (en) Catheter with fluid medication injectors
US6210392B1 (en) Method for treating a wall of a blood vessel
US8066690B2 (en) Method for delivering medication into an arterial wall for prevention of restenosis
WO1997025096A9 (fr) Catheter a injecteurs de medicaments fluides
US6280414B1 (en) Method and apparatus for local delivery of therapeutic agent
EP1035884B1 (fr) Systeme de catheter a espace mort specifie utile pour l'administration d'un bolus de liquide de faible volume
EP0768098B1 (fr) Cathéter avec injecteurs de médicament fluide
US20080140001A1 (en) Fluid Delivery Apparatus And Methods
EP1165176A1 (fr) Dispositif medical gonflable muni d'elements d'injection destines a l'injection dans des zones localisees
EP1051215A1 (fr) Dispositif permettant d'injecter un fluide dans la paroi d'un vaisseau sanguin
CA2178234C (fr) Catheter avec injecteurs de medicaments liquides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000721

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB

A4 Supplementary search report drawn up and despatched

Effective date: 20010220

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE FR GB

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61M 29/00 A, 7A 61M 31/00 B, 7A 61M 25/10 B, 7A 61M 29/02 B

17Q First examination report despatched

Effective date: 20010601

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020716